INRA - News of the Toulouse Midi-Pyrénées Centre

All the news

The Ika4 protein shown here is the result of the spontaneous assembly of two smaller, identical proteins designed to assemble.

News

14 Dec 2018

A new protein designed by an Artificial Intelligence

The objective of Artificial Intelligence (AI) is to enable a computer to (better) solve human problems. In Toulouse, an AI using "automated reasoning" algorithms has been able to design an artificial hyper-stable self-assembling protein. This is the result of work involving the MIAT unit, in an informal international collaboration with Belgium and Japan.

maize cob. © INRA, WEBER Jean

Press release

12 Dec 2018

MON 810 and NK603 GM Maize: No Effects Detected on Rat Health or Metabolism

A diet based on MON 810 or NK603 transgenic maize does not affect the health or metabolism of rats, under the conditions of the GMO 90+1 project. This unprecedented study performed by a research consortium led by INRA brought together a number of partners, including Inserm. The research was performed as part of the Risk’OGM program funded by the French Ministry of Ecological and Inclusive Transition.

Sunflower with downy mildew

News

10 Dec 2018

Towards more sustainable resistances to downy mildew in sunflower

Downy mildew is a sunflower disease that can lead to an almost total loss of yield in the case of serious attacks. Thanks to long work on valorization of natural genomic resources and to the development of new genotyping technologies, scientists and technicians at the plant-microorganisms interactions laboratory (LIPM) have improved understanding of infection mechanisms which should help to reinforce disease resistance of sunflower in the field.

phenomobile

News

20 Nov 2018

Observing and characterising plants: a B-to-B event on high-throughput phenotyping

Observing and characterising plants: a B-to-B event on advances in high-throughput phenotyping to serve the breeding, nutrition and protection of plants.

News

29 Oct 2018

PrediTox, the start-up that evaluates the carcinogenic potential of your compounds

The commercial development of a technology from TOXALIM designed to evaluate the carcinogenic potential of different compounds.

1